SlideShare ist ein Scribd-Unternehmen logo
1 von 9
Downloaden Sie, um offline zu lesen
Global Markets for Treatment and Diagnosis of Sexually
Transmitted Diseases
Report Details:
Published:January 2013
No. of Pages: 141
Price: Single User License – US$5450




REPORT HIGHLIGHTS
This report provides:
•An overview of the markets for the diagnoses of and treatments for sexually transmitted diseases,
 including bacterial vaginosis, candidiasis, chancroid, chlamydia, genital herpes, genital warts,
 gonorrhea, hepatitis B, HIV/AIDS, pediculosis pubis, syphilis, and trichomoniasis.
•Analyses of global market trends, with data from 2011 and 2012, and projections of compound
 annual growth rates (CAGRs) through 2017.
•Identifications of common STDs, citing risk factors, incidence, and mortality for each.
•Discussion of products on the market.
•A list of current and potential competitors in the market and their market shares.
•Comprehensive company profiles of major players in the industry.
REPORT SCOPE
INTRODUCTION
REASONS FOR DOING THE STUDY
This report provides the reader with a detailed analysis of the global sexually transmitted disease
(STD) diagnostic and treatment markets. It also discusses technological developments, future
trends and emerging opportunities.
The major objectives of this study are:
•To assess the technology developments.
•To identify the driving factors for demand.
•To make available the most current and reliable information on market size.
•To estimate the global supply and demand scenario broken down by disease and geographical
 regions.
•To estimate the growth rate in demand.
•To estimate the projected global supply and demand scenario over the next five years and to
 analyze it via application sectors as well as product types.
•To identify the factors influencing this industry and make appropriate recommendations.
Projections for STD diagnostic and treatment applications will be made for geographical regions
including the Americas (i.e., U.S., Canada, Central America [including Mexico], South America);
Europe, Middle East, Russia and Africa (EMRA); and Asia (Japan, China, India, Australia other
Oceanic countries).
SCOPE OF REPORT
This market report organizes information from diverse sources into a cohesive report that includes
a disease overview, industry structure, diagnostic products, pharmaceutical products, emerging
technology, regulations by region and patents sections.
METHODOLOGY/INFORMATION SOURCES
The data for this report was gathered from primary and secondary sources. Sources include
information obtained from industry analysts; manufacturer and company reports; industry trade
journals; medical journals; and industry associations. Additional information was obtained through
the U.S. Patent and Trademark Office (USPTO), U.S. Securities and Exchange Commission
(SEC) filings, The World Health Organization (WHO), the Organization for Economic Cooperation
and Development (OECD), the Pharmaceutical Research and Manufacturing Association,
UNAIDS and Epocrates.

Get your copy of this report @
http://www.reportsnreports.com/reports/213312-global-markets-for-treatment-and-diagnosis-of-sexually-
transmitted-diseases.html

Major points covered in Table of Contents of this report include
TABLE OF CONTENTS
Chapter- 1: INTRODUCTION
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
METHODOLOGY/INFORMATION SOURCES
INTENDED AUDIENCE
ANALYST CREDENTIALS
RELATED BCC REPORTS
BCC ONLINE SERVICES
DISCLAIMER
Chapter- 2: SUMMARY
Table Summary : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY
TRANSMITTED DISEASES, THROUGH 2017
Figure Summary : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY
TRANSMITTED DISEASES, 2011 AND 2017
Chapter- 3: INDUSTRY OVERVIEW
EPIDEMIOLOGY AND ETIOLOGY OF SEXUALLY TRANSMITTED DISEASES
DIAGNOSIS OF STD
VACCINES
MARKET ANALYSIS BY DISEASE
MERGERS AND ACQUISITIONS
Chapter- 4: DISEASE OVERVIEW
DIAGNOSTIC TESTING
BACTERIAL VAGINOSIS
CANDIDIASIS
CHANCROID (VENEREAL ULCERS)
CHLAMYDIA
GENITAL HERPES
GENITAL WARTS/HUMAN PAPILLOMAVIRUS
GONORRHEA
HEPATITIS B AND C
HERPES SIMPLEX VIRUS (SEE GENITAL HERPES)
HIV/AIDS
PEDICULOSIS PUBIS
PELVIC INFLAMMATORY DISEASE (PID)
SCABIES
SYPHILIS
TRICHOMONIASIS
STD TRENDS
Table 13 : CAUSATIVE ORGANISMS FOR SEXUALLY TRANSMITTED DISEASES
Chapter- 5: STD DIAGNOSIS AND TREATMENT OPTIONS
DIAGNOSTIC OPTIONS, BY TYPE
GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS, BY DISEASE
PROJECTED GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS, BY REGION
STD PHARMACEUTICAL PRODUCTS, BY DISEASE
GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS, BY REGION
OPPORTUNITIES IN THE STD DIAGNOSIS AND TREATMENT MARKET
Chapter- 6: THE AMERICAS MARKET
DIAGNOSTIC PRODUCTS IN THE AMERICAS
PHARMACEUTICAL TREATMENTS IN THE AMERICAS
ANTIBIOTIC RESISTANCE IN TREATING STDS
THE U.S.
CANADA
Chapter- 7: THE EMRA MARKET
STD DIAGNOSTIC PRODUCT MARKET IN THE EMRA
STD PHARMACEUTICAL TREATMENTS IN THE EMRA
ANNUAL INCIDENCES OF STD DISEASE IN THE EMRA
Chapter- 8: THE ASIAN MARKET
DIAGNOSTIC PRODUCTS
STD TREATMENT OPTIONS IN ASIA
REGIONAL DISEASE PREVALENCE
Chapter- 9: REGULATIONS
CREATING DRUG TREATMENTS
REGIONAL REGULATIONS
Chapter- 10: PHARMACEUTICAL TREATMENT PIPELINE
EMERGING TRENDS IN DIAGNOSTIC PRODUCTS
EMERGING TRENDS IN PHARMACEUTICAL PRODUCTS
PHARMACEUTICAL TREATMENT PRODUCT PIPELINE
Chapter- 11: PATENT ANALYSIS
PHARMACEUTICAL PATENTS ISSUED BY COMPANY, APPROVAL DATE AND DISEASE
DIAGNOSTIC PATENTS ISSUED BY COMPANY, APPROVAL DATE AND DISEASE
PATENTS ISSUED BY COMPANY
PATENTS ISSUED BY COUNTRY
PATENTS ISSUED BY DISEASE
Chapter- 12: COMPANY PROFILES
ABBOTT LABORATORIES
ALERE
ALFA SCIENTIFIC DESIGNS
ATLAS LINK BIOTECH CO, LTD.
BAYER AG
BECTON DICKINSON
BIOMERIEUX, INC.
BIO-RAD LABORATORIES
BOEHRINGER INGELHEIM GMBH
BRISTOL-MYERS SQUIBB COMPANY
CREATIVE DIAGNOSTICS
DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS, INC.
DIASORIN
ENZO BIOCHEM
FIRST DIAGNOSTIC LLC
GENENTECH (SEE ROCHE)
GEN-PROBE, INC. (SEE HOLOGIC)
GILEAD SCIENCES, INC.
GLAXOSMITHKLINE
HOLOGIC/GEN-PROBE
HOME ACCESS HEALTH, INC.
IMMUNOSTICS
IND DIAGNOSTIC, INC.
INVERNESS MEDICAL INNOVATIONS (SEE ALERE)
JANSSEN THERAPEUTICS (FORMERLY TIBOTEC THERAPEUTICS)
MERCK & COMPANY, INC.
MERIDIAN BIOSCIENCE
NOVARTIS PHARMACEUTICAL CORPORATION
ORASURE TECHNOLOGIES, INC.
ORTHO CLINICAL DIAGNOSTICS
PFIZER, INC.
PRINCETON BIOMEDITECH CORPORATION
QIAGEN BENELUX BV
QUIDEL
REMEL/THERMOFISHER SCIENTIFIC
ROCHE LABORATORIES (HOFFMANN-LA ROCHE INC.)
SEKISUI DIAGNOSTICS
SHANGHAI KEHUA BIO-ENGINEERING CO, LTD.
STANDARD DIAGNOSTICS, INC.
TRINITY BIOTECH PLC
VERTEX PHARMACEUTICALS
VIIV HEALTHCARE
LIST OF TABLES
Summary Table : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY
TRANSMITTED DISEASES, THROUGH 2017
Table 1 : MAJOR MANUFACTURERS OF AUTOMATED STD TESTS, 2012
Table 2 : MAJOR MANUFACTURERS OF RAPID AND LABORATORY DIAGNOSTIC STD KITS,
2012
Table 3 : MAJOR MANUFACTURERS OF VACCINES FOR STDS
Table 4 : HPV DIAGNOSTIC PRODUCTS, MANUFACTURER AND MARKET SHARE, 2011
Table 5 : GONORRHEA DIAGNOSTIC PRODUCT MANUFACTURERS AND PRODUCT NAMES
Table 6 : MAJOR GONORRHEA TREATMENT MANUFACTURERS AND PRODUCTS
Table 7 : HEPATITIS A, B AND C DIAGNOSTIC PRODUCT MARKET SHARE AND REVENUES
BY TYPE OF TEST, 2011
Table 8 : MARKET STANDING OF MAJOR HEPATITIS B AND C TREATMENT
MANUFACTURERS BY REVENUES, 2011
Table 9 : HIV DIAGNOSTIC PRODUCT MARKET SHARE AND REVENUES BY TYPE, 2011
Table 10 : HIV/AIDS TREATMENT MANUFACTURER MARKET STANDING BY REVENUES,
2011
Table 11 : NUMBER OF DIAGNOSTIC AND PHARMACEUTICAL MANUFACTURERS, BY
DISEASE TREATED, WITH REVENUES AND MARKET SHARE, 2011
Table 12 : SELECTED MERGERS AND ACQUISITIONS, 2008-2012
Table 13 : CAUSATIVE ORGANISMS FOR SEXUALLY TRANSMITTED DISEASES
Table 14 : CURRENT DIAGNOSTIC TESTS FOR BACTERIAL VAGINITIS
Table 15 : CURRENT TREATMENTS FOR BACTERIAL VAGINITIS
Table 16 : DIAGNOSTIC TESTS FOR CANDIDIASIS
Table 17 : TREATMENTS FOR VULVOVAGINAL CANDIDIASIS
Table 18 : CURRENT MEDICATIONS USED TO TREAT CHANCROID ULCERS
Table 19 : CURRENTLY AVAILABLE CHLAMYDIA TESTS BY BRAND NAME, TYPE AND
MANUFACTURER, 2012
Table 20 : CURRENT MEDICATIONS USED TO TREAT CHLAMYDIA
Table 21 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF GENITAL HERPESBY
BRAND NAME, TYPE AND MANUFACTURER, 2012
Table 22 : CURRENT TREATMENTS FOR GENITAL HERPESBY BRAND NAME, GENERIC
NAME AND MANUFACTURER, 2012
Table 23 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HPV BY BRAND NAME,
TYPE AND MANUFACTURER, 2012
Table 24 : MEDICATIONS USED TO TREAT GENITAL WARTS BY BRAND NAME, GENERIC
NAME AND MANUFACTURER
Table 25 : CURRENT PRODUCTS USED TO DIAGNOSE GONORRHEA
Table 26 : CURRENT MEDICATIONS USED TO TREAT GONORRHEA
Table 27 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HEPATITIS B AND C BY
BRAND NAME, TYPE AND MANUFACTURER, 2012
Table 28 : VACCINES AND MEDICATIONS FOR THE TREATMENT OF HEPATITIS, 2012
Table 29 : CDC CLASSIFICATION OF HIV INFECTION
Table 30 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HIV/AIDS BY BRAND
NAME, TYPE AND MANUFACTURER, 2012
Table 31 : HIV LIFE CYCLE
Table 32 : FDA-APPROVED GENERIC DRUGS FOR TREATMENT OF HIV, 2012
Table 33 : CURRENTLY APPROVED PHARMACEUTICAL PRODUCTS FOR TREATMENT OF
HIV/AIDS BY BRAND NAME, GENERIC NAME AND MANUFACTURER, 2012
Table 34 : HIV TREATMENT MARKET, BY MANUFACTURER
Table 35 : CURRENT TREATMENTS FOR PEDICULOSIS PUBIS BRAND NAME, GENERIC
NAME AND MANUFACTURER
Table 36 : CURRENT TREATMENTS FOR PID BRAND NAME, GENERIC NAME AND
MANUFACTURER
Table 37 : CURRENT TREATMENTS FOR SCABIES BRAND NAME, GENERIC NAME AND
MANUFACTURER
Table 38 : STAGES OF SYPHILIS
Table 39 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF SYPHILIS BY BRAND
NAME, TYPE AND MANUFACTURER, 2012
Table 40 : DIAGNOSTIC ASSAYS FOR DETECTION OF TRICHOMONAS WITH BRAND NAME,
TYPE AND MANUFACTURER
Table 41 : CURRENT MEDICATIONS FOR THE TREATMENT OF TRICHOMONAS
Table 42 : PROJECTED GLOBAL MARKET FOR DIAGNOSTIC PRODUCTS USED TO DETECT
STDS BY DISEASE, THROUGH 2017
Table 43 : PROJECTED GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS BY REGION,
THROUGH 2017
Table 44 : PROJECTED GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS,
THROUGH 2017
Table 45 : PROJECTED GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS BY
REGION, THROUGH 2017
Table 46 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE AMERICAS,
THROUGH 2017
Table 47 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE
AMERICAS, BY DISEASE, THROUGH 2017
Table 48 : ESTIMATED ANNUAL NUMBER OF PREGNANT WOMEN WITH AN STD IN THE
U.S.
Table 49 : ANNUAL INCIDENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S., 2010
Table 50 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE EMRA,
THROUGH 2017
Table 51 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE EMRA
BY DISEASE, THROUGH 2017
Table 52 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN ASIA BY DISEASE,
THROUGH 2017
Table 53 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN ASIA BY
DISEASE, THROUGH 2017
Table 54 : PROCESS OF CREATING DRUG TREATMENTS IN THE U.S.
Table 55 : SEXUALLY TRANSMITTED DISEASE PHARMACEUTICAL PRODUCT PIPELINE,
2012
Table 56 : STD PHARMACEUTICAL PATENTS BY PATENT NUMBER, DISEASE, COMPANY,
PRODUCT DESCRIPTION, AND APPROVAL DATE FEBRUARY 2006–OCTOBER 2012
Table 57 : STD DIAGNOSTIC PATENTS BY PATENT NUMBER, DISEASE, COMPANY,
PRODUCT DESCRIPTION AND APPROVAL DATE MARCH 2005-OCTOBER 2012
Table 58 : STD PHARMACEUTICAL PRODUCT PATENTS, BY MAJOR COMPANY JANUARY
2005–OCTOBER 2012
Table 59 : STD DIAGNOSIS AND TREATMENT PATENTS BY COUNTRY JANUARY
2005–OCTOBER 2012
Table 60 : PATENTS ISSUED FOR DIAGNOSIS AND TREATMENT OF STDS BY DISEASE,
MARCH 2005–OCTOBER 2012
Table 61 : ABBOTT PHARMACEUTICAL PRODUCTS
Table 62 : ABBOTT DIAGNOSTIC PRODUCTS
Table 63 : ALERE DIAGNOSTIC PRODUCTS
Table 64 : ALFA SCIENTIFIC DESIGNS DIAGNOSTIC PRODUCTS
Table 65 : ATLAS LINK BIOTECH DIAGNOSTIC PRODUCTS
Table 66 : BAYER PHARMACEUTICAL PRODUCTS
Table 67 : BECTON DICKINSON DIAGNOSTIC PRODUCTS
Table 68 : BIOMERIEUX DIAGNOSTIC PRODUCTS
Table 69 : BIO-RAD LABORATORIES DIAGNOSTIC PRODUCTS
Table 70 : BOEHRINGER INGELHEIM PHARMACEUTICAL PRODUCTS
Table 71 : BRISTOL-MEYERS SQUIBB PHARMACEUTICAL PRODUCTS
Table 72 : CREATIVE DIAGNOSTICS DIAGNOSTIC PRODUCTS
Table 73 : DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS DIAGNOSTIC PRODUCTS
Table 74 : DIASORIN DIAGNOSTIC PRODUCTS
Table 75 : ENZO BIOCHEM DIAGNOSTIC PRODUCTS
Table 76 : FIRST DIAGNOSTIC DIAGNOSTIC PRODUCTS
Table 77 : GILEAD SCIENCES PHARMACEUTICAL PRODUCTS
Table 78 : GLAXOSMITHKLINE PHARMACEUTICAL PRODUCTS
Table 79 : HOLOGIC/GEN-PROBE DIAGNOSTIC PRODUCTS
Table 80 : HOME ACCESS HEALTH DIAGNOSTIC PRODUCTS
Table 81 : IMMUNOSTICS DIAGNOSTIC PRODUCTS
Table 82 : IND DIAGNOSTIC, INC DIAGNOSTIC PRODUCTS
Table 83 : JANSSEN THERAPEUTICS PHARMACEUTICAL PRODUCTS
Table 84 : MERCK PHARMACEUTICAL PRODUCTS
Table 85 : MERIDIAN BIOSCIENCE DIAGNOSTIC PRODUCTS
Table 86 : NOVARTIS DIAGNOSTIC PRODUCTS
Table 87 : ORASURE TECHNOLOGIES DIAGNOSTIC PRODUCTS
Table 88 : ORTHO CLINICAL DIAGNOSTICS DIAGNOSTIC PRODUCTS
Table 89 : PFIZER PHARMACEUTICAL PRODUCTS
Table 90 : PRINCETON BIOMEDITECH DIAGNOSTIC PRODUCTS
Table 91 : QIAGEN DIAGNOSTIC PRODUCTS
Table 92 : QUIDEL DIAGNOSTIC PRODUCTS
Table 93 : REMEL/THERMOFISHER SCIENTIFIC DIAGNOSTIC PRODUCTS
Table 94 : ROCHE PHARMACEUTICAL PRODUCTS
Table 95 : ROCHE DIAGNOSTIC PRODUCTS
Table 96 : SEKISUI DIAGNOSTICS DIAGNOSTIC PRODUCTS
Table 97 : SHANGHAI KEHUA BIO-ENGINEERING DIAGNOSTIC PRODUCTS
Table 98 : STANDARD DIAGNOSTICS DIAGNOSTIC PRODUCTS
Table 99 : TRINITY BIOTECH DIAGNOSTIC PRODUCTS
Table 100 : VERTEX PHARMACEUTICALS PHARMACEUTICAL PRODUCTS
Table 101 : VIIV HEALTHCARE PHARMACEUTICAL PRODUCTS
LIST OF FIGURES
Summary Figure : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY
TRANSMITTED DISEASES, 2011 AND 2017
Figure 1 : TOP PHARMACEUTICAL MANUFACTURERS IN THE HEPATITIS MARKET AND
THEIR MARKET SHARE, 2011
Figure 2 : MARKET SHARE OF LEADING COMPANIES IN THE HIV/AIDS TREATMENT
MARKET, 2011
Figure 3 : 2011 MARKET SHARE FOR BRANDED HIV DRUGS, BY MANUFACTURER
Figure 4 : MARKET SHARE FOR TYPES OF TESTS USED TO DIAGNOSE STDS, 2012
Figure 5 : GLOBAL STD DIAGNOSTIC MARKET, BY REGION 2012 AND 2017
Figure 6 : GLOBAL STD PHARMACEUTICAL MARKET BY REGION 2012 AND 2017
Figure 7 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE AMERICAS BY DISEASE,
2012 AND 2017
Figure 8 : MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE AMERICAS BY
DISEASE, 2012 AND 2017
Figure 9 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE EMRA BY DISEASE, 2012
AND 2017
Figure 10 : MARKET FOR STD TREATMENT PRODUCTS IN THE EMRA BY DISEASE, 2012
AND 2017
Figure 11 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN ASIA BY DISEASE, 2012 AND
2017
Figure 12 : MARKET FOR STD TREATMENT PRODUCTS IN ASIA BY DISEASE, 2012 AND
2017
Contact: sales@reportsandreports.com for more information.

Weitere ähnliche Inhalte

Andere mochten auch

Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016
Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016
Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016ReportsnReports
 
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...ReportsnReports
 
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...ReportsnReports
 
Consumer Foodservice in Finland
Consumer Foodservice in FinlandConsumer Foodservice in Finland
Consumer Foodservice in FinlandReportsnReports
 
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...ReportsnReports
 

Andere mochten auch (8)

Laringe
LaringeLaringe
Laringe
 
Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016
Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016
Vietnamese Foodservice: The Future of Foodservice in Vietnam to 2016
 
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...
United Kingdom Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems...
 
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...
South Africa Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Mult...
 
Leitfaden für ehrenamtliche flüchtlingshilfe
Leitfaden für ehrenamtliche flüchtlingshilfeLeitfaden für ehrenamtliche flüchtlingshilfe
Leitfaden für ehrenamtliche flüchtlingshilfe
 
Koes4
Koes4Koes4
Koes4
 
Consumer Foodservice in Finland
Consumer Foodservice in FinlandConsumer Foodservice in Finland
Consumer Foodservice in Finland
 
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Depe...
 

Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases

  • 1. Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases Report Details: Published:January 2013 No. of Pages: 141 Price: Single User License – US$5450 REPORT HIGHLIGHTS This report provides: •An overview of the markets for the diagnoses of and treatments for sexually transmitted diseases, including bacterial vaginosis, candidiasis, chancroid, chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, HIV/AIDS, pediculosis pubis, syphilis, and trichomoniasis. •Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017. •Identifications of common STDs, citing risk factors, incidence, and mortality for each. •Discussion of products on the market. •A list of current and potential competitors in the market and their market shares. •Comprehensive company profiles of major players in the industry. REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY This report provides the reader with a detailed analysis of the global sexually transmitted disease (STD) diagnostic and treatment markets. It also discusses technological developments, future trends and emerging opportunities. The major objectives of this study are: •To assess the technology developments. •To identify the driving factors for demand. •To make available the most current and reliable information on market size. •To estimate the global supply and demand scenario broken down by disease and geographical regions. •To estimate the growth rate in demand. •To estimate the projected global supply and demand scenario over the next five years and to analyze it via application sectors as well as product types. •To identify the factors influencing this industry and make appropriate recommendations. Projections for STD diagnostic and treatment applications will be made for geographical regions including the Americas (i.e., U.S., Canada, Central America [including Mexico], South America);
  • 2. Europe, Middle East, Russia and Africa (EMRA); and Asia (Japan, China, India, Australia other Oceanic countries). SCOPE OF REPORT This market report organizes information from diverse sources into a cohesive report that includes a disease overview, industry structure, diagnostic products, pharmaceutical products, emerging technology, regulations by region and patents sections. METHODOLOGY/INFORMATION SOURCES The data for this report was gathered from primary and secondary sources. Sources include information obtained from industry analysts; manufacturer and company reports; industry trade journals; medical journals; and industry associations. Additional information was obtained through the U.S. Patent and Trademark Office (USPTO), U.S. Securities and Exchange Commission (SEC) filings, The World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), the Pharmaceutical Research and Manufacturing Association, UNAIDS and Epocrates. Get your copy of this report @ http://www.reportsnreports.com/reports/213312-global-markets-for-treatment-and-diagnosis-of-sexually- transmitted-diseases.html Major points covered in Table of Contents of this report include TABLE OF CONTENTS Chapter- 1: INTRODUCTION REASONS FOR DOING THE STUDY SCOPE OF REPORT METHODOLOGY/INFORMATION SOURCES INTENDED AUDIENCE ANALYST CREDENTIALS RELATED BCC REPORTS BCC ONLINE SERVICES DISCLAIMER Chapter- 2: SUMMARY Table Summary : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES, THROUGH 2017 Figure Summary : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES, 2011 AND 2017 Chapter- 3: INDUSTRY OVERVIEW EPIDEMIOLOGY AND ETIOLOGY OF SEXUALLY TRANSMITTED DISEASES DIAGNOSIS OF STD VACCINES MARKET ANALYSIS BY DISEASE MERGERS AND ACQUISITIONS Chapter- 4: DISEASE OVERVIEW DIAGNOSTIC TESTING
  • 3. BACTERIAL VAGINOSIS CANDIDIASIS CHANCROID (VENEREAL ULCERS) CHLAMYDIA GENITAL HERPES GENITAL WARTS/HUMAN PAPILLOMAVIRUS GONORRHEA HEPATITIS B AND C HERPES SIMPLEX VIRUS (SEE GENITAL HERPES) HIV/AIDS PEDICULOSIS PUBIS PELVIC INFLAMMATORY DISEASE (PID) SCABIES SYPHILIS TRICHOMONIASIS STD TRENDS Table 13 : CAUSATIVE ORGANISMS FOR SEXUALLY TRANSMITTED DISEASES Chapter- 5: STD DIAGNOSIS AND TREATMENT OPTIONS DIAGNOSTIC OPTIONS, BY TYPE GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS, BY DISEASE PROJECTED GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS, BY REGION STD PHARMACEUTICAL PRODUCTS, BY DISEASE GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS, BY REGION OPPORTUNITIES IN THE STD DIAGNOSIS AND TREATMENT MARKET Chapter- 6: THE AMERICAS MARKET DIAGNOSTIC PRODUCTS IN THE AMERICAS PHARMACEUTICAL TREATMENTS IN THE AMERICAS ANTIBIOTIC RESISTANCE IN TREATING STDS THE U.S. CANADA Chapter- 7: THE EMRA MARKET STD DIAGNOSTIC PRODUCT MARKET IN THE EMRA STD PHARMACEUTICAL TREATMENTS IN THE EMRA ANNUAL INCIDENCES OF STD DISEASE IN THE EMRA Chapter- 8: THE ASIAN MARKET DIAGNOSTIC PRODUCTS STD TREATMENT OPTIONS IN ASIA REGIONAL DISEASE PREVALENCE Chapter- 9: REGULATIONS CREATING DRUG TREATMENTS REGIONAL REGULATIONS
  • 4. Chapter- 10: PHARMACEUTICAL TREATMENT PIPELINE EMERGING TRENDS IN DIAGNOSTIC PRODUCTS EMERGING TRENDS IN PHARMACEUTICAL PRODUCTS PHARMACEUTICAL TREATMENT PRODUCT PIPELINE Chapter- 11: PATENT ANALYSIS PHARMACEUTICAL PATENTS ISSUED BY COMPANY, APPROVAL DATE AND DISEASE DIAGNOSTIC PATENTS ISSUED BY COMPANY, APPROVAL DATE AND DISEASE PATENTS ISSUED BY COMPANY PATENTS ISSUED BY COUNTRY PATENTS ISSUED BY DISEASE Chapter- 12: COMPANY PROFILES ABBOTT LABORATORIES ALERE ALFA SCIENTIFIC DESIGNS ATLAS LINK BIOTECH CO, LTD. BAYER AG BECTON DICKINSON BIOMERIEUX, INC. BIO-RAD LABORATORIES BOEHRINGER INGELHEIM GMBH BRISTOL-MYERS SQUIBB COMPANY CREATIVE DIAGNOSTICS DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS, INC. DIASORIN ENZO BIOCHEM FIRST DIAGNOSTIC LLC GENENTECH (SEE ROCHE) GEN-PROBE, INC. (SEE HOLOGIC) GILEAD SCIENCES, INC. GLAXOSMITHKLINE HOLOGIC/GEN-PROBE HOME ACCESS HEALTH, INC. IMMUNOSTICS IND DIAGNOSTIC, INC. INVERNESS MEDICAL INNOVATIONS (SEE ALERE) JANSSEN THERAPEUTICS (FORMERLY TIBOTEC THERAPEUTICS) MERCK & COMPANY, INC. MERIDIAN BIOSCIENCE NOVARTIS PHARMACEUTICAL CORPORATION ORASURE TECHNOLOGIES, INC. ORTHO CLINICAL DIAGNOSTICS PFIZER, INC.
  • 5. PRINCETON BIOMEDITECH CORPORATION QIAGEN BENELUX BV QUIDEL REMEL/THERMOFISHER SCIENTIFIC ROCHE LABORATORIES (HOFFMANN-LA ROCHE INC.) SEKISUI DIAGNOSTICS SHANGHAI KEHUA BIO-ENGINEERING CO, LTD. STANDARD DIAGNOSTICS, INC. TRINITY BIOTECH PLC VERTEX PHARMACEUTICALS VIIV HEALTHCARE LIST OF TABLES Summary Table : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES, THROUGH 2017 Table 1 : MAJOR MANUFACTURERS OF AUTOMATED STD TESTS, 2012 Table 2 : MAJOR MANUFACTURERS OF RAPID AND LABORATORY DIAGNOSTIC STD KITS, 2012 Table 3 : MAJOR MANUFACTURERS OF VACCINES FOR STDS Table 4 : HPV DIAGNOSTIC PRODUCTS, MANUFACTURER AND MARKET SHARE, 2011 Table 5 : GONORRHEA DIAGNOSTIC PRODUCT MANUFACTURERS AND PRODUCT NAMES Table 6 : MAJOR GONORRHEA TREATMENT MANUFACTURERS AND PRODUCTS Table 7 : HEPATITIS A, B AND C DIAGNOSTIC PRODUCT MARKET SHARE AND REVENUES BY TYPE OF TEST, 2011 Table 8 : MARKET STANDING OF MAJOR HEPATITIS B AND C TREATMENT MANUFACTURERS BY REVENUES, 2011 Table 9 : HIV DIAGNOSTIC PRODUCT MARKET SHARE AND REVENUES BY TYPE, 2011 Table 10 : HIV/AIDS TREATMENT MANUFACTURER MARKET STANDING BY REVENUES, 2011 Table 11 : NUMBER OF DIAGNOSTIC AND PHARMACEUTICAL MANUFACTURERS, BY DISEASE TREATED, WITH REVENUES AND MARKET SHARE, 2011 Table 12 : SELECTED MERGERS AND ACQUISITIONS, 2008-2012 Table 13 : CAUSATIVE ORGANISMS FOR SEXUALLY TRANSMITTED DISEASES Table 14 : CURRENT DIAGNOSTIC TESTS FOR BACTERIAL VAGINITIS Table 15 : CURRENT TREATMENTS FOR BACTERIAL VAGINITIS Table 16 : DIAGNOSTIC TESTS FOR CANDIDIASIS Table 17 : TREATMENTS FOR VULVOVAGINAL CANDIDIASIS Table 18 : CURRENT MEDICATIONS USED TO TREAT CHANCROID ULCERS Table 19 : CURRENTLY AVAILABLE CHLAMYDIA TESTS BY BRAND NAME, TYPE AND MANUFACTURER, 2012 Table 20 : CURRENT MEDICATIONS USED TO TREAT CHLAMYDIA Table 21 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF GENITAL HERPESBY BRAND NAME, TYPE AND MANUFACTURER, 2012
  • 6. Table 22 : CURRENT TREATMENTS FOR GENITAL HERPESBY BRAND NAME, GENERIC NAME AND MANUFACTURER, 2012 Table 23 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HPV BY BRAND NAME, TYPE AND MANUFACTURER, 2012 Table 24 : MEDICATIONS USED TO TREAT GENITAL WARTS BY BRAND NAME, GENERIC NAME AND MANUFACTURER Table 25 : CURRENT PRODUCTS USED TO DIAGNOSE GONORRHEA Table 26 : CURRENT MEDICATIONS USED TO TREAT GONORRHEA Table 27 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HEPATITIS B AND C BY BRAND NAME, TYPE AND MANUFACTURER, 2012 Table 28 : VACCINES AND MEDICATIONS FOR THE TREATMENT OF HEPATITIS, 2012 Table 29 : CDC CLASSIFICATION OF HIV INFECTION Table 30 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF HIV/AIDS BY BRAND NAME, TYPE AND MANUFACTURER, 2012 Table 31 : HIV LIFE CYCLE Table 32 : FDA-APPROVED GENERIC DRUGS FOR TREATMENT OF HIV, 2012 Table 33 : CURRENTLY APPROVED PHARMACEUTICAL PRODUCTS FOR TREATMENT OF HIV/AIDS BY BRAND NAME, GENERIC NAME AND MANUFACTURER, 2012 Table 34 : HIV TREATMENT MARKET, BY MANUFACTURER Table 35 : CURRENT TREATMENTS FOR PEDICULOSIS PUBIS BRAND NAME, GENERIC NAME AND MANUFACTURER Table 36 : CURRENT TREATMENTS FOR PID BRAND NAME, GENERIC NAME AND MANUFACTURER Table 37 : CURRENT TREATMENTS FOR SCABIES BRAND NAME, GENERIC NAME AND MANUFACTURER Table 38 : STAGES OF SYPHILIS Table 39 : CURRENT DIAGNOSTIC PRODUCTS FOR DETECTION OF SYPHILIS BY BRAND NAME, TYPE AND MANUFACTURER, 2012 Table 40 : DIAGNOSTIC ASSAYS FOR DETECTION OF TRICHOMONAS WITH BRAND NAME, TYPE AND MANUFACTURER Table 41 : CURRENT MEDICATIONS FOR THE TREATMENT OF TRICHOMONAS Table 42 : PROJECTED GLOBAL MARKET FOR DIAGNOSTIC PRODUCTS USED TO DETECT STDS BY DISEASE, THROUGH 2017 Table 43 : PROJECTED GLOBAL MARKET FOR STD DIAGNOSTIC PRODUCTS BY REGION, THROUGH 2017 Table 44 : PROJECTED GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS, THROUGH 2017 Table 45 : PROJECTED GLOBAL MARKET FOR STD PHARMACEUTICAL PRODUCTS BY REGION, THROUGH 2017 Table 46 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE AMERICAS, THROUGH 2017 Table 47 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE
  • 7. AMERICAS, BY DISEASE, THROUGH 2017 Table 48 : ESTIMATED ANNUAL NUMBER OF PREGNANT WOMEN WITH AN STD IN THE U.S. Table 49 : ANNUAL INCIDENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S., 2010 Table 50 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE EMRA, THROUGH 2017 Table 51 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE EMRA BY DISEASE, THROUGH 2017 Table 52 : PROJECTED MARKET FOR STD DIAGNOSTIC PRODUCTS IN ASIA BY DISEASE, THROUGH 2017 Table 53 : PROJECTED MARKET FOR STD PHARMACEUTICAL PRODUCTS IN ASIA BY DISEASE, THROUGH 2017 Table 54 : PROCESS OF CREATING DRUG TREATMENTS IN THE U.S. Table 55 : SEXUALLY TRANSMITTED DISEASE PHARMACEUTICAL PRODUCT PIPELINE, 2012 Table 56 : STD PHARMACEUTICAL PATENTS BY PATENT NUMBER, DISEASE, COMPANY, PRODUCT DESCRIPTION, AND APPROVAL DATE FEBRUARY 2006–OCTOBER 2012 Table 57 : STD DIAGNOSTIC PATENTS BY PATENT NUMBER, DISEASE, COMPANY, PRODUCT DESCRIPTION AND APPROVAL DATE MARCH 2005-OCTOBER 2012 Table 58 : STD PHARMACEUTICAL PRODUCT PATENTS, BY MAJOR COMPANY JANUARY 2005–OCTOBER 2012 Table 59 : STD DIAGNOSIS AND TREATMENT PATENTS BY COUNTRY JANUARY 2005–OCTOBER 2012 Table 60 : PATENTS ISSUED FOR DIAGNOSIS AND TREATMENT OF STDS BY DISEASE, MARCH 2005–OCTOBER 2012 Table 61 : ABBOTT PHARMACEUTICAL PRODUCTS Table 62 : ABBOTT DIAGNOSTIC PRODUCTS Table 63 : ALERE DIAGNOSTIC PRODUCTS Table 64 : ALFA SCIENTIFIC DESIGNS DIAGNOSTIC PRODUCTS Table 65 : ATLAS LINK BIOTECH DIAGNOSTIC PRODUCTS Table 66 : BAYER PHARMACEUTICAL PRODUCTS Table 67 : BECTON DICKINSON DIAGNOSTIC PRODUCTS Table 68 : BIOMERIEUX DIAGNOSTIC PRODUCTS Table 69 : BIO-RAD LABORATORIES DIAGNOSTIC PRODUCTS Table 70 : BOEHRINGER INGELHEIM PHARMACEUTICAL PRODUCTS Table 71 : BRISTOL-MEYERS SQUIBB PHARMACEUTICAL PRODUCTS Table 72 : CREATIVE DIAGNOSTICS DIAGNOSTIC PRODUCTS Table 73 : DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS DIAGNOSTIC PRODUCTS Table 74 : DIASORIN DIAGNOSTIC PRODUCTS Table 75 : ENZO BIOCHEM DIAGNOSTIC PRODUCTS Table 76 : FIRST DIAGNOSTIC DIAGNOSTIC PRODUCTS Table 77 : GILEAD SCIENCES PHARMACEUTICAL PRODUCTS
  • 8. Table 78 : GLAXOSMITHKLINE PHARMACEUTICAL PRODUCTS Table 79 : HOLOGIC/GEN-PROBE DIAGNOSTIC PRODUCTS Table 80 : HOME ACCESS HEALTH DIAGNOSTIC PRODUCTS Table 81 : IMMUNOSTICS DIAGNOSTIC PRODUCTS Table 82 : IND DIAGNOSTIC, INC DIAGNOSTIC PRODUCTS Table 83 : JANSSEN THERAPEUTICS PHARMACEUTICAL PRODUCTS Table 84 : MERCK PHARMACEUTICAL PRODUCTS Table 85 : MERIDIAN BIOSCIENCE DIAGNOSTIC PRODUCTS Table 86 : NOVARTIS DIAGNOSTIC PRODUCTS Table 87 : ORASURE TECHNOLOGIES DIAGNOSTIC PRODUCTS Table 88 : ORTHO CLINICAL DIAGNOSTICS DIAGNOSTIC PRODUCTS Table 89 : PFIZER PHARMACEUTICAL PRODUCTS Table 90 : PRINCETON BIOMEDITECH DIAGNOSTIC PRODUCTS Table 91 : QIAGEN DIAGNOSTIC PRODUCTS Table 92 : QUIDEL DIAGNOSTIC PRODUCTS Table 93 : REMEL/THERMOFISHER SCIENTIFIC DIAGNOSTIC PRODUCTS Table 94 : ROCHE PHARMACEUTICAL PRODUCTS Table 95 : ROCHE DIAGNOSTIC PRODUCTS Table 96 : SEKISUI DIAGNOSTICS DIAGNOSTIC PRODUCTS Table 97 : SHANGHAI KEHUA BIO-ENGINEERING DIAGNOSTIC PRODUCTS Table 98 : STANDARD DIAGNOSTICS DIAGNOSTIC PRODUCTS Table 99 : TRINITY BIOTECH DIAGNOSTIC PRODUCTS Table 100 : VERTEX PHARMACEUTICALS PHARMACEUTICAL PRODUCTS Table 101 : VIIV HEALTHCARE PHARMACEUTICAL PRODUCTS LIST OF FIGURES Summary Figure : GLOBAL MARKET FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES, 2011 AND 2017 Figure 1 : TOP PHARMACEUTICAL MANUFACTURERS IN THE HEPATITIS MARKET AND THEIR MARKET SHARE, 2011 Figure 2 : MARKET SHARE OF LEADING COMPANIES IN THE HIV/AIDS TREATMENT MARKET, 2011 Figure 3 : 2011 MARKET SHARE FOR BRANDED HIV DRUGS, BY MANUFACTURER Figure 4 : MARKET SHARE FOR TYPES OF TESTS USED TO DIAGNOSE STDS, 2012 Figure 5 : GLOBAL STD DIAGNOSTIC MARKET, BY REGION 2012 AND 2017 Figure 6 : GLOBAL STD PHARMACEUTICAL MARKET BY REGION 2012 AND 2017 Figure 7 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE AMERICAS BY DISEASE, 2012 AND 2017 Figure 8 : MARKET FOR STD PHARMACEUTICAL PRODUCTS IN THE AMERICAS BY DISEASE, 2012 AND 2017 Figure 9 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN THE EMRA BY DISEASE, 2012 AND 2017 Figure 10 : MARKET FOR STD TREATMENT PRODUCTS IN THE EMRA BY DISEASE, 2012
  • 9. AND 2017 Figure 11 : MARKET FOR STD DIAGNOSTIC PRODUCTS IN ASIA BY DISEASE, 2012 AND 2017 Figure 12 : MARKET FOR STD TREATMENT PRODUCTS IN ASIA BY DISEASE, 2012 AND 2017 Contact: sales@reportsandreports.com for more information.